Xavier Duportet

Xavier Duportet is the co-founder & CEO at Eligo Bioscience, pioneering first-in-class in vivo CRISPR & gene editing modalities to address serious diseases in immuno-inflammation & oncology. Xavier is also the co-founder and President at Deeptech Founders, a startup acceleration program for entrepreneurial scientists. Xavier is a member of the Strategic Advisory Board at Université Paris-Saclay and Universcience, as well as a Senior Advisor at the French Ministry of Foreign Affairs & Ministry of Economy, Finance and Industry. With a background in Synthetic Biology and Molecular Biology, Xavier has been involved in a variety of innovative projects and ventures, bridging the gap between science and business to address pressing global issues.